Benzene, a volatile organic compound (VOC) with widespread industrial applications, poses severe health risks to humans even at trace levels. Its genotoxic effects, which involve direct damage to cellular DNA and genetic material leading to mutations, are strongly linked to cancer and blood disorders, making its control a critical priority for workplace safety and environmental […]
A future for autonomous vehicles in the UK? Lessons from the US
One of the final bills passed by the outgoing Sunak government was the Automated Vehicles Act (2024), designed to make provisions for the possible rollout of autonomous vehicles in the future. If the new Starmer government is to continue this work, then lessons need to be learnt from the US, where the deployment of autonomous […]
Can nuclear power work with renewables to achieve net zero?
Decarbonising electricity in the UK is far from straightforward. Government plans for the nation’s future electricity supply rely heavily on renewables, supported by gas power during periods of low renewable output. In this article, Professor Juan Matthews considers how nuclear energy can provide an alternative to gas power and support a future renewables-heavy grid, and […]
Regional policy for biomanufacturing in the North-West chemical sector
There is an urgent need for the chemical manufacturing sector to transition to alternative, sustainable carbon-based feedstocks, moving away from reliance on petrochemical sources. Large urban areas, such as the north-west of England, generate substantial amounts of waste rich in carbon, which are processed for energy generation via direct incineration or biogas production. Here, Dr […]
Building the bioeconomy
Current manufacturing processes across all industrial sectors rely on petrochemicals, either to power them, or as starting points for their product. This over reliance on finite fossil resources is having a detrimental impact on the health of the world and its population. Professor Aline Miller explains how industrial biotechnology can break this addiction to petrochemicals […]
Energy consumption: solving the storage problem
To combat climate change, all developed economies have set the goal of carbon-neutrality by 2050. This means securing more energy from renewable sources. Achieving a high proportion of renewable energy production in the UK and other developed countries is only possible with suitable energy storage infrastructure, to bridge periods of low or no power generation from […]
Regulation of human embryo models is urgent
Human embryo models are created from stem cells and provide opportunities to study early embryo development in ways that would generally be impermissible if real human embryos were used. Here, Dr Jonathan Lewis and Professor Soren Holm argue that with human embryo models becoming more advanced, regulations governing human embryo research need to be established […]
Untangling the threads: addressing microfibre pollution
As clothes are washed and worn, tiny fibres below 5mm in length are broken off or released from the fabric itself, which are called microfibres. With increasing concerns over the persistence of this pollution, Libby Allen, Dr Claudia Henninger and Jingyi Li are exploring preventative solutions to reduce pollution released from the laundering of clothes. […]
Electricity access vs toxic lead pollution: tackling waste from solar power in sub-Saharan Africa
Millions of short-lived solar energy devices are being sold to households across sub-Saharan Africa each year as a strategy to increase access to electricity. However, the current lack of infrastructure to safely manage the resulting toxic waste flow raises significant environmental, human health, and social justice concerns. Here, Dr Christopher Kinally and Dr Alejandro Gallego […]
Unjamming the (bio)printer: how can regulatory reform unleash new and advanced biomaterials?
3D bioprinting technologies hold huge potential to transform patient care and treatment, delivering the next generation of personalised medicine. But current legislative boundaries are poorly defined, and the pathways to approval are unclear, creating unnecessary delays and costs in getting these new technologies to patients. Here, Dr Marco Domingos from the Bioprinting Technology Platform argues […]
- 1
- 2
- 3
- …
- 10
- Next Page »